Metabolic Testing Solutions: Market Research Report

January 2015 | 273 pages | ID: M7E7BE271C2EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Metabolic Testing Solutions in US$ Thousand by the following Product Segments: ECGs/EKGs, Metabolic Carts, CPET Systems, and Others. The market is also analyzed by the following Technologies: VO2 Max Analysis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 91 companies including many key and niche players such as -

• AEI Technologies, Inc.
• Bodystat Limited
• CareFusion Corporation
• CORTEX Biophysik GmbH
• COSMED

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Product Segments
Cardio-pulmonary Exercise Testing
Metabolic Cart
Electrocardiogram
Product Technologies
VO2 Max Analysis
RMR Analysis
Body Composition Analysis

II. EXECUTIVE SUMMARY

1. OUTLOOK

Endemic Lifestyle Diseases – Cornerstone to Growth in Metabolic Testing Solutions
Current & Future Analysis

2. INDUSTRY OVERVIEW

Gas Exchange Physiology Plays a Defining Role in Maintaining Normal Body Metabolism
Major End-Use and Application Markets

Table 1. Global Metabolic Testing Solutions Market (2014): Percentage Share Breakdown of Value Sales by End-Use Site (includes corresponding Graph/Chart)

Table 2. Global Metabolic Testing Solutions Market (2014): Percentage Share Breakdown of Value Sales by Application (includes corresponding Graph/Chart)

Aging Population and Growing Incidence of Targeted Conditions Drive Demand for CPET Systems

Table 3. Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)

Table 4. Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)

Obesity Statistics

Table 5. Overweight & Obese Individuals as % of Total Population by Geographic Region (includes corresponding Graph/Chart)

Table 6. Global Obesity Population by Country (2013 (includes corresponding Graph/Chart))

Table 7. Global Prevalence of Diabetic Mellitus (2014 & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region for Population in Age Group 20-79 Years (includes corresponding Graph/Chart)

Developing Economies Offer Significant Potential
Technological Advances Drive Demand for CPET Systems
Treadmill Testing Takes Precedence over Alternatives in CPET
Wider Adoption Potential Exists for CPET Systems in Clinical Application
Several Barriers Prevent Widespread Adoption of CPET in Clinical Settings
Overview of Select Barriers
Clinician Level Barriers
Institutional Barriers
Healthcare-Wide Barriers
Technology-Related Barriers
Metabolic Cart – The Gold Standard in Energy Expenditure Measurement
Major Indications of Metabolic Carts
Increasing Health and Fitness Consciousness Drives Demand for Body Composition Analysis Systems
BIA - The Most Preferred Body Composition Analysis Technique
Costs and Accuracy Benefits Drive Demand for BIA
Segmental Bioimpedance Gains Traction in Body Composition Analysis
Vector Analysis – A New Direction in Bioimpedance Data Analysis

3. PRODUCT OVERVIEW

Metabolic Testing Solutions
Cardio-pulmonary Exercise Testing
Common Parameters analyzed with CPET
Metabolic Cart
Electrocardiogram
Metabolic Testing Technologies
VO2 Max Analysis
vVo2 Max
RMR Analysis
Body Composition Analysis

4. PRODUCT INNOVATIONS/INTRODUCTIONS

Tanita Unveils Ironman Body Composition Monitors
Schiller Unveils CARDIOVIT FT-1
RJL Systems Unveils BC 4. 0 BIA Software
seca and Coach Tom Shaw Unveil Premiere Body Composition Analyzer
BIOSPACE Unveils InBody 370 Body Composition Analyzer
seca Unveils seca mBCA 514 Body Composition Analyzer
Withings Unveils Smart Body Analyzer Scale

5. RECENT INDUSTRY ACTIVITY

Hill-Rom Takes Over Welch Allyn
Becton, Dickinson Takes Over CareFusion
MGC Diagnostics Takes Over MediSoft
KORR Partners with Biospace
MGC Diagnostics Partners with Frontera Strategies

6. FOCUS ON SELECT PLAYERS

AEI Technologies, Inc. (US)
Bodystat Limited (UK)
CareFusion Corporation (US)
CORTEX Biophysik GmbH (Germany)
COSMED (Italy)
GE Healthcare (UK)
Geratherm Medical AG (Germany)
Hologic, Inc. (US)
InBody Co., Ltd. (South Korea)
Iworx Systems, Inc. (US)
Jawon Medical Co. Ltd. (South Korea)
KORR Medical Technologies, Inc. (US)
Laica SpA (Italy)
MGC Diagnostics Corporation (US)
Microlife Medical Home Solutions, Inc. (US)
Mindray Medical International Limited (China)
Mortara Instrument, Inc. (US)
Nihon Kohden Corporation (Japan)
Noraxon U. S. A., Inc. (US)
Omron Healthcare, Inc. (US)
Parvo Medics (US)
Philips Healthcare (Netherlands)
RJL Systems, Inc. (US)
Schiller AG (Switzerland)
seca GmbH & Co. KG. (Germany)
Spacelabs Healthcare, Inc. (US)
Tanita Corporation (Japan)
Welch Allyn, Inc. (US)

7. GLOBAL MARKET PERSPECTIVE

Table 8. World Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 9. World Historic Review for Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 10. World 14-Year Perspective for Metabolic Testing Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Market by Product Segment

Table 11. World Recent Past, Current & Future Analysis for ECGs/EKGs in Metabolic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 12. World Historic Review for ECGs/EKGs in Metabolic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 13. World 14-Year Perspective for ECGs/EKGs in Metabolic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 14. World Recent Past, Current & Future Analysis for Metabolic Carts by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 15. World Historic Review for Metabolic Carts by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 16. World 14-Year Perspective for Metabolic Carts by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 17. World Recent Past, Current & Future Analysis for CPET Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 18. World Historic Review for CPET Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 19. World 14-Year Perspective for CPET Systems by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 20. World Recent Past, Current & Future Analysis for Other Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 21. World Historic Review for Other Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 22. World 14-Year Perspective for Other Metabolic Testing Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Market Analysis by Technology

Table 23. World Recent Past, Current & Future Analysis for VO2 Max Analysis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 24. World Historic Review for VO2 Max Analysis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 25. World 14-Year Perspective for VO2 Max Analysis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 26. World Recent Past, Current & Future Analysis for Other Metabolic Testing Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 27. World Historic Review for Other Metabolic Testing Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 28. World 14-Year Perspective for Other Metabolic Testing Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Current & Future Analysis
Growing Menace of Obesity provides a Strong Case for Metabolic Testing Solutions
Product Launches
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 29. US Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 30. US Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 31. US 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 32. US Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 33. US Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 34. US 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

Market Analysis

Table 35. Canadian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 36. Canadian Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 37. Canadian 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 38. Canadian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 39. Canadian Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 40. Canadian 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Current & Future Analysis
Key Players
B. Market Analytics

Table 41. Japanese Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 42. Japanese Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 43. Japanese 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 44. Japanese Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 45. Japanese Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 46. Japanese 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

Market Analysis

Table 47. European Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 48. European Historic Review for Metabolic Testing Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 49. European 14-Year Perspective for Metabolic Testing Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 50. European Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 51. European Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 52. European 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 53. European Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 54. European Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 55. European 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Current & Future Analysis
Product Launch
B. Market Analytics

Table 56. French Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 57. French Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 58. French 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 59. French Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 60. French Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 61. French 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Current & Future Analysis
Key Players
Product Launches
B. Market Analytics

Table 62. German Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 63. German Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 64. German 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 65. German Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 66. German Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 67. German 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Current & Future Analysis
Key Players
B. Market Analytics

Table 68. Italian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 69. Italian Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 70. Italian 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 71. Italian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 72. Italian Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 73. Italian 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Current & Future Analysis
Key Players
B. Market Analytics

Table 74. UK Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 75. UK Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 76. UK 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 77. UK Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 78. UK Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 79. UK 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4E. SPAIN

Market Analysis

Table 80. Spanish Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 81. Spanish Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 82. Spanish 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 83. Spanish Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 84. Spanish Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 85. Spanish 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4F. RUSSIA

Market Analysis

Table 86. Russian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 87. Russian Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 88. Russian 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 89. Russian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 90. Russian Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 91. Russian 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Current & Future Analysis
Product Launches
Strategic Corporate Development
Key Players
B. Market Analytics

Table 92. Rest of Europe Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 93. Rest of Europe Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 94. Rest of Europe 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 95. Rest of Europe Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 96. Rest of Europe Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 97. Rest of Europe 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Current & Future Analysis
Increasing Prevalence of Cardiopulmonary Diseases Drives Demand for CPET Systems
Key Players
B. Market Analytics

Table 98. Asia-Pacific Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 99. Asia-Pacific Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 100. Asia-Pacific 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 101. Asia-Pacific Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 102. Asia-Pacific Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 103. Asia-Pacific 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis

Table 104. Latin American Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 105. Latin American Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 106. Latin American 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 107. Latin American Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 108. Latin American Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 109. Latin American 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

Market Analysis

Table 110. Rest of World Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 111. Rest of World Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 112. Rest of World 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

Table 113. Rest of World Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)

Table 114. Rest of World Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

Table 115. Rest of World 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 91 (including Divisions/Subsidiaries - 95)
The United States (32)
Canada (1)
Japan (3)
Europe (40)
  France (2)
  Germany (12)
  The United Kingdom (5)
  Italy (5)
  Rest of Europe (16)
Asia-Pacific (Excluding Japan) (17)
Latin America (1)
Middle East (1)